Celadon Partners SPV 24 4
4 · Senti Biosciences, Inc. · Filed Mar 14, 2025
Insider Transaction Report
Form 4
Celadon Partners SPV 24
10% Owner
Transactions
- Conversion
Common Stock
2025-03-10+9,777,000→ 9,777,000 total - Conversion
Series A Convertible Preferred Stock
2025-03-10−9,777→ 0 total→ Common Stock (9,777,000 underlying)
Footnotes (1)
- [F1]Each share of Series A Convertible Preferred Stock (the "Series A Preferred Stock") was convertible into 1,000 shares of Common Stock either (i) automatically, at the Issuer's option or (ii) upon the election of the holder. On March 10, 2025, the Issuer exercised its right to automatically convert each share of Series A Preferred Stock, resulting in the acquisition of 9,777,000 shares of Common Stock. The Series A Preferred Stock had no expiration date.